Search Term: Oklahoma
Please scroll down to see the matching trials.
(0.8912)
Brain Tumor Treatments: Oklahoma
(0.7742)
Brainstem Glioma
(0.7742)
Brain Tumor Activism
(0.7742)
Letter Writing Wizard
(0.7742)
Brain Tumor Activism
(0.7742)
Medulloblastoma
(0.7742)
Untitled Document
Sorry - There were no pages found that contain that search phrase.
 |
 |
 |
 |
|
 |
Treatment |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Tulsa, OK USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Oklahoma City, OK USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Tulsa, OK USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Oklahoma City, OK USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Tulsa, OK USA |
 |
11/27/2005 |
 |
 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Oklahoma City, OK USA |
 |
11/27/2005 |
 |
 |
 |
Details |
 |
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
 |
Oklahoma City, OK USA |
 |
11/26/2005 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
 |
Tulsa, OK USA |
 |
11/06/2005 |
 |
 |
 |
|